MYC and esophageal cancer: In this study, flavopiridol alone or in combination with the chemotherapeutic agent NPT or in combination with the targeted agent BMS-754807 significantly inhibited high c-Myc expressing OE19 esophageal cancer subcutaneous xenograft tumor growth without significantly changing average mice body weight.